Related references
Note: Only part of the references are listed.COVID-19 alters thinking and management in metabolic diseases
Carel W. le Roux
NATURE REVIEWS ENDOCRINOLOGY (2021)
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany
Marion Ludwig et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
Shiying Shao et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Metformin: Up to Date
Silvia Sciannimanico et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions
Habib Yaribeygi et al.
JOURNAL OF DIABETES RESEARCH (2020)
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
Pantelis Sarafidis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pseudomonas aeruginosa Induced Host Epithelial Cell Mitochondrial Dysfunction
Nicholas M. Maurice et al.
SCIENTIFIC REPORTS (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
Beatriz Fernandez-Fernandez et al.
CLINICAL KIDNEY JOURNAL (2019)
Metformin Mediates Protection against Legionella Pneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species
Chiaki Kajiwara et al.
JOURNAL OF IMMUNOLOGY (2018)
SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials
Robert Puckrin et al.
ACTA DIABETOLOGICA (2018)
Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa
Brahmchetna Bedi et al.
FASEB JOURNAL (2017)
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data The AHRQ Elixhauser Comorbidity Index
Brian J. Moore et al.
MEDICAL CARE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway
Guangming Tang et al.
ONCOTARGET (2017)
Metformin: historical overview
Clifford J. Bailey
DIABETOLOGIA (2017)
Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study
Javier Gorricho et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma
Brahmchetna Bedi et al.
INFECTION AND IMMUNITY (2016)
Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study
Anil Mor et al.
BMJ OPEN (2016)
Metformin: A Hopeful Promise in Aging Research
Marta G. Novelle et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation
Wei Xie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Association between Use of Oral Anti-Diabetic Drugs and the Risk of Sepsis: A Nested Case-Control Study
Chia-Jen Shih et al.
SCIENTIFIC REPORTS (2015)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Activation of AMPK Enhances Neutrophil Chemotaxis and Bacterial Killing
Dae Won Park et al.
MOLECULAR MEDICINE (2013)
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
James P. Garnett et al.
THORAX (2013)
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study
D. T. Eurich et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study
Christian Fynbo Christiansen et al.
CRITICAL CARE (2013)
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
Nils Ekstrom et al.
BMJ OPEN (2012)
Metformin overdose causes platelet mitochondrial dysfunction in humans
Alessandro Protti et al.
CRITICAL CARE (2012)
Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
Marjolein J. Willemen et al.
DIABETES CARE (2011)
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
Sonal Singh et al.
THORAX (2011)
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials
M. Monami et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia, inhibits fibrinolysis during human endotoxemia
Michiel E. Stegenga et al.
BLOOD (2008)
Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients
M. C. Foss-Freitas et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Type 2 diabetes and pneumonia outcomes - A population-based cohort study
Jette B. Kornum et al.
DIABETES CARE (2007)
High glucose impairs superoxide production from isolated blood neutrophils
A Perner et al.
INTENSIVE CARE MEDICINE (2003)
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
T Ishii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
